BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/3/2022 7:54:39 AM | Browse: 273 | Download: 590
 |
Received |
|
2022-02-01 20:17 |
|
Peer-Review Started |
|
2022-02-01 20:19 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2022-02-24 01:27 |
|
Revised |
|
2022-03-09 21:15 |
|
Second Decision |
|
2022-07-04 03:03 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2022-07-06 03:10 |
|
Articles in Press |
|
2022-07-06 03:10 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2022-06-30 12:10 |
|
Typeset the Manuscript |
|
2022-07-27 01:52 |
|
Publish the Manuscript Online |
|
2022-08-03 07:54 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Observational Study |
| Article Title |
Evaluating the best treatment for multifocal hepatocellular carcinoma: A propensity score-matched analysis
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Matteo Risaliti, Ilenia Bartolini, Claudia Campani, Umberto Arena, Carlotta Xodo, Valentina Adotti, Martina Rosi, Antonio Taddei, Paolo Muiesan, Amedeo Amedei, Giacomo Batignani and Fabio Marra |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Fabio Marra, MD, Professor, Department of Experimental and Clinical Medicine, AOU Careggi, Largo Brambilla 3, Florence 50134, Italy. fabio.marra@unifi.it |
| Key Words |
Hepatocellular carcinoma; Multifocal hepatocellular carcinoma; Liver resection; Trans-arterial chemoembolisation; Guidelines; Liver tumour management |
| Core Tip |
Hepatocellular carcinoma (HCC) is a leading cause of death and often shows up in a multifocal form. Trans-Arterial ChemoEmbolization (TACE) is the most frequently employed treatment for this patient category. Since patients with multifocal HCC are a heterogeneous group, previous data suggest that liver resection (LR) could be a safe and effective procedure. A propensity score-matched analysis has been performed to compare LR and TACE in terms of post-procedure morbidity and survival. Despite the limited number of patients, LR conferred longer disease-free survival with similar overall survival compared to TACE. Subgroup analyses identified the patients benefiting more from a specific treatment. |
| Publish Date |
2022-08-03 07:54 |
| Citation |
Risaliti M, Bartolini I, Campani C, Arena U, Xodo C, Adotti V, Rosi M, Taddei A, Muiesan P, Amedei A, Batignani G, Marra F. Evaluating the best treatment for multifocal hepatocellular carcinoma: A propensity score-matched analysis. World J Gastroenterol 2022; 28(29): 3981-3993 |
| URL |
https://www.wjgnet.com/1007-9327/full/v28/i29/3981.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v28.i29.3981 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
